This is absolutely fascinating research, thank you for sharing!
You mention in the Many Americas paper that drug preference is a complex combination of socio-economic factors as well as marketing. But what we've also seen is how some counties are repeatedly choosing more expensive drugs...
Do you have any intuitions on what the other PCA variables may indicate apart from what you mentioned, in your model? It's a very broad question, but will understanding this maybe help in making policy based decisions on drug pricing in the USA?
This is absolutely fascinating research, thank you for sharing! You mention in the Many Americas paper that drug preference is a complex combination of socio-economic factors as well as marketing. But what we've also seen is how some counties are repeatedly choosing more expensive drugs... Do you have any intuitions on what the other PCA variables may indicate apart from what you mentioned, in your model? It's a very broad question, but will understanding this maybe help in making policy based decisions on drug pricing in the USA?